Fibroma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
[[Category:Up-To-Date]] | {{CMG}}{{AE}} {{M.N}} | ||
==Overview== | |||
There are no secondary preventive measures for fibroma. | |||
==Secondary prevention== | |||
There are no secondary preventive measures for fibroma. | |||
==References== | |||
{{reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Gynecology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 15:33, 18 July 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]
Overview
There are no secondary preventive measures for fibroma.
Secondary prevention
There are no secondary preventive measures for fibroma.